NeoGenomics, Inc. (FRA:NG9)

NeoGenomics Revenue

NeoGenomics had revenue of $187.80M USD in the quarter ending September 30, 2025, with 11.90% growth. This brings the company's revenue in the last twelve months to $709.16M, up 10.10% year-over-year. In the year 2024, NeoGenomics had annual revenue of $660.57M with 11.65% growth.

• Revenue (ttm): $709.16M
• Revenue Growth: +10.10%
• P/S Ratio: 2.42
• Revenue / Employee: $322.35K
• Employees: 2,200
• Market Cap: 1.46B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	660.57M	68.92M	11.65%
Dec 31, 2023	591.64M	81.92M	16.07%
Dec 31, 2022	509.73M	25.40M	5.24%
Dec 31, 2021	484.33M	39.88M	8.97%
Dec 31, 2020	444.45M	35.62M	8.71%
Dec 31, 2019	408.83M	132.09M	47.73%
Dec 31, 2018	276.74M	36.49M	15.19%
Dec 31, 2017	240.25M	8.44M	3.64%
Dec 31, 2016	231.81M	132.01M	132.27%
Dec 31, 2015	99.80M	12.73M	14.62%
Dec 31, 2014	87.07M	20.60M	31.00%
Dec 31, 2013	66.47M	6.60M	11.02%
Dec 31, 2012	59.87M	16.38M	37.68%
Dec 31, 2011	43.48M	9.11M	26.51%
Dec 31, 2010	34.37M	4.90M	16.63%
Dec 31, 2009	29.47M	9.45M	47.23%
Dec 31, 2008	20.02M	8.51M	73.97%
Dec 31, 2007	11.50M	5.03M	77.65%
Dec 31, 2006	6.48M	-	-